Methylation, the MTHFR Gene, and PMDD: What’s the Connection?
Understanding Methylation and the MTHFR Gene
“Methylation” is one of the body’s most important chemical processes — a bit like a biological switch that helps regulate DNA activity, neurotransmitter balance, and detoxification. In the brain, methylation supports the production and recycling of serotonin, dopamine, and noradrenaline — the very neurotransmitters involved in mood and emotional regulation.
The MTHFR gene (methylenetetrahydrofolate reductase) makes an enzyme that converts dietary folate and folic acid into the active form, 5-methyltetrahydrofolate (5-MTHF). This active folate is essential for recycling homocysteine into methionine, which fuels methylation reactions throughout the body.
Certain common variants — especially C677T and A1298C — can slow this conversion, leading to lower methylation efficiency and potentially affecting mood, hormone metabolism, and brain function.
How Methylation Links to PMS and PMDD
Genetic and environmental factors together shape PMDD risk. In a landmark twin study, Huo et al. (2007) showed that PMDD heritability is around 56%, suggesting genes that affect neurotransmitter and hormone regulation — like MTHFR — may be part of the picture.
A 2025 study by Zeitoun & El-Sohemy in the British Journal of Nutrition found that women with the TT variant of MTHFR C677T had worse premenstrual mood symptoms if their dietary folate intake was low. When folate intake was higher, their symptoms were comparable to women with normal enzyme function. In short: dietary folate can buffer the effects of reduced methylation capacity.
Follow-up findings published in NutraIngredients-USA (2025) confirmed this — women with both low folate intake and the MTHFR risk genotype had significantly higher rates of premenstrual depression, while adequate folate intake protected against these effects.
What the Broader Evidence Shows
Research across psychiatry supports the idea that MTHFR variants can influence susceptibility to mood disorders:
Zhang et al. (2022) found that MTHFR C677T is linked to depression, bipolar disorder, and anxiety — all of which overlap with PMDD.
Wan et al. (2018) reported that reduced MTHFR activity leads to lower brain methylation and impaired serotonin metabolism.
Together, these studies suggest that women with MTHFR variants may be more sensitive to normal hormonal changes and therefore more vulnerable to mood symptoms in the luteal phase.
How to Support Healthy Methylation: Folate in Diet and Supplements
If methylation efficiency is reduced, improving folate and B-vitamin intake is one of the simplest and safest ways to support the system.
Food Sources of Folate
According to the British Dietetic Association (BDA), you can naturally boost folate by:
Eating plenty of leafy green vegetables such as spinach, kale, spring greens, and broccoli.
Adding beans, chickpeas, and lentils to salads, soups, and curries.
Choosing fortified breakfast cereals or breads (check labels for “fortified with folic acid”).
Including citrus fruits, nuts, and seeds for an extra folate boost.
Steaming or microwaving vegetables instead of boiling, since folate is water-soluble and can be lost in cooking water.
Folate Supplements
The standard UK recommendation for adults is 200 µg of folate daily from food.
For those with MTHFR variants or suspected methylation issues, some may prefer methylated folate (L-5-MTHF) instead of standard folic acid — this form doesn’t rely on MTHFR conversion.
Avoid taking more than 1 mg (1000 µg) folic acid daily unless medically advised, as excessive doses can mask vitamin B12 deficiency.
Vitamins B6, B12, and riboflavin also support methylation, so a B-complex supplement or balanced diet is useful.
What This Means for Women with PMDD
The science suggests that methylation efficiency and folate status may influence how your brain responds to hormonal changes. For some women, improving folate and B-vitamin intake could complement existing treatments for PMS and PMDD — particularly if there’s a family history of mood disorders or genetic predisposition.
That said, methylation is only one factor. PMDD remains a complex neurohormonal condition, and nutritional support should sit alongside evidence-based treatments such as SSRIs, hormonal modulation, and lifestyle interventions.
At Sirona Health Ltd, I take an integrated approach — combining hormonal, nutritional, and psychological care to personalise treatment for every woman.
-
It’s a gene that helps your body activate folate into its usable form for methylation — a process essential for mood and hormone regulation.
-
Yes, with a varied diet rich in leafy greens, beans, and fortified cereals, most people can meet their needs. However, women with PMDD or MTHFR variants may benefit from extra folate support.
-
If you have an MTHFR variant or poor folate metabolism, methylated folate (L-5-MTHF) can be more effective, but discuss this with your doctor first.
-
Emerging research suggests that adequate folate intake can reduce premenstrual mood symptoms, particularly in women with MTHFR variants. It’s not a cure, but it may complement other treatments.
-
Yes. Very high doses (over 1 mg/day) can mask vitamin B12 deficiency. Stick to recommended levels unless advised otherwise by a clinician.